Compound Detail
CHEMBL3989908
ENASIDENIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL3989908 |
| Name | ENASIDENIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | DYLUUSLLRIQKOE-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
4
Targets
26
Activities
2
Assay Types
10
PK Parameters
20
Publications
4
Known Names
8
Indications
Molecular Properties
473.4
MW (Da)
4.29
ALogP
8
HBA
3
HBD
108.7
PSA (Ų)
0.46
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2017 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Hematologic Neoplasms Liver Diseases Multiple Myeloma Neoplasms
ATC Classification
L01XM01
enasidenib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 22 meas. best 8.4
Kd 4 meas. best 4.93
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 8.4 | 6.9433 | 4.0 | 3 |
| Isocitrate dehydrogenase [NADP], mitochondrial CHEMBL3991501 | IC50 | 8.05 | 6.6719 | 9.0 | 16 |
| Isocitrate dehydrogenase [NADP] cytoplasmic CHEMBL2007625 | IC50 | 6.17 | 5.735 | 677.0 | 2 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.04 | 5.04 | 9020.0 | 1 |
| Isocitrate dehydrogenase [NADP] cytoplasmic CHEMBL2007625 | Kd | 4.93 | 4.89 | 11700.0 | 4 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 13987.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 87552.0 | ng.hr.mL-1 | Mus musculus |
| CL | 5.99 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 6009.97 | nM | Mus musculus |
| Cmax | 13505.01 | nM | Mus musculus |
| F | 125.2 | % | Mus musculus |
| MRT | 4.9 | hr | Mus musculus |
| MRT | 7.45 | hr | Mus musculus |
| T1/2 | 2.71 | hr | Mus musculus |
| T1/2 | 6.98 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36952395 | 10.1021/acs.jmedchem.3c00203 | Isocitrate dehydrogenase [NADP] cytoplasmic | 18 |
| 37706660 | 10.1021/acs.jmedchem.3c00835 | ADMET | 15 |
| 37706660 | 10.1021/acs.jmedchem.3c00835 | Isocitrate dehydrogenase [NADP], mitochondrial | 7 |
| 32679449 | 10.1016/j.ejmech.2020.112491 | Isocitrate dehydrogenase [NADP], mitochondrial | 5 |
| 37706660 | 10.1021/acs.jmedchem.3c00835 | TF-1 | 4 |
| 29847930 | 10.1021/acs.jmedchem.8b00159 | Isocitrate dehydrogenase [NADP], mitochondrial | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 3 |
| 37706660 | 10.1021/acs.jmedchem.3c00835 | Unchecked | 3 |
| 32143887 | 10.1016/j.bmcl.2020.127070 | Isocitrate dehydrogenase [NADP] cytoplasmic | 3 |
| 32143887 | 10.1016/j.bmcl.2020.127070 | Isocitrate dehydrogenase [NADP], mitochondrial | 3 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| 37706660 | 10.1021/acs.jmedchem.3c00835 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 32071674 | 10.1021/acsmedchemlett.9b00509 | Isocitrate dehydrogenase [NADP] cytoplasmic | 2 |
| 32071674 | 10.1021/acsmedchemlett.9b00509 | Unchecked | 2 |
Data from ChEMBL 36 via Core Engine